Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation

被引:115
|
作者
Rouet-Benzineb, P
Buhler, JM
Dreyfus, P
Delcourt, A
Dorent, R
Perennec, J
Crozatier, B
Harf, A
Lafuma, C
机构
[1] Fac Med, INSERM U492, F-94010 Creteil, France
[2] Fac Med, INSERM U421, F-94010 Creteil, France
[3] Fac Med, INSERM U400, F-94010 Creteil, France
[4] CENS, F-91191 Gif Sur Yvette, France
[5] CHU Pitie Salpetriere, Serv Anat Pathol, F-75013 Paris, France
[6] CHU Pitie Salpetriere, Serv Chirurg Cardiaque, F-75013 Paris, France
关键词
dilated cardiomyopathy; matrix metalloproteinases; tissue inhibitors of matrix metalloproteinases myosin-heavy chain proteolysis;
D O I
10.1016/S1388-9842(99)00048-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: End-stage of human dilated cardiomyopathy (DCM) is characterized by myocyte loss and fibrosis, and associated with ventricular dilatation and reduced cardiac function. Matrix metalloproteinases (MMPs) and their natural tissue inhibitors (TIMPs) have been involved in the myocardial remodeling. Aims: To evaluate the potential role of matrix gelatinases (MMP-2 and MMP-9) in DCM, the balance between gelatinases and TIMPs and the gelatinase localization were investigated in left free wall ventricles from six normal donors and six patients with DCM at the transplantation time. Methods: TIMP-(1, 2, 3 and 4) mRNAs were analyzed by quantitative reverse transcription-polymerase chain reaction (RT-PCR). TIMP-1 and -2 protein content was assessed by ELISA. MMP-2 and MMP-9 expression were examined by zymography and immunological techniques. Results: All TIMPs were down-regulated in DCM hearts, especially TIMP-1 (reduced by 80%). Gel zymography revealed similar activity of MMP-2 and MMP-9 in both tissues. By in situ zymography and immunohistochemistry, active and immunoreactive gelatinases were pericardiomyocyte in control hearts and intracardiomyocyte in DCM hearts. Intracellular MMPs were associated with sarcomeric structure in DCM. To estimate a putative role of these gelatinases, several sarcomeric contractile proteins were digested in vitro by purified active MMP-9. Only myosin-heavy chain was cleaved in vitro giving 180-, 120-, 80- and 20-kDa proteolytic fragments. In vivo, two major myosin-heavy chain proteolytic fragments (80 and 20 kDa) were detected by specific monoclonal antibody against myosin-heavy chain in DCM left ventricular homogenates, only. Conclusions: Taken together, these data highly suggest that MMP-2 and MMP-9 may be involved in the disorganization of the contractile apparatus in DCM hearts. (C) 1999 European Society of Cardiology. All rights reserved.
引用
收藏
页码:337 / 352
页数:16
相关论文
共 50 条
  • [41] Immunoexpression of MMP-8, MMP-9 and TIMP-2 in dilated cardiomyopathy
    Mitrut, Radu
    Stepan, Alex Emilian
    Margaritescu, Claudiu
    Andreiana, Bianca Catalina
    Kesse, Ana Maria
    Simionescu, Cristiana Eugenia
    Militaro, Constantin
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2019, 60 (01): : 119 - 124
  • [42] Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: Increased serum MMP-9 level in acute rejection
    Kuyvenhoven, JP
    Verspaget, HW
    Gao, Q
    Ringers, J
    Smit, VTHBM
    Lamers, CBHW
    Van Hoek, B
    TRANSPLANTATION, 2004, 77 (11) : 1646 - 1652
  • [43] Differential Vesicular Distribution and Trafficking of MMP-2, MMP-9, and Their Inhibitors in Astrocytes
    Sbai, Oualid
    Ould-Yahoui, Adlane
    Ferhat, Lotfi
    Gueye, Yatma
    Bernard, Anne
    Charrat, Eliane
    Mehanna, Ali
    Risso, Jean-Jacques
    Chauvin, Jean-Paul
    Fenouillet, Emmanuel
    Rivera, Santiago
    Khrestchatisky, Michel
    GLIA, 2010, 58 (03) : 344 - 366
  • [44] Regulation of MMP-2 and MMP-9 expression in childhood osteosarcoma by inducers and inhibitors
    Roomi, MW
    Ivanov, V
    Niedzwiecki, A
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 646 - 646
  • [45] Matrix metalloproteinases MMP-2 and MMP-9 in denervated muscle and injured nerve
    Kherif, S
    Dehaupas, M
    Lafuma, C
    Fardeau, M
    Alameddine, HS
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1998, 24 (04) : 309 - 319
  • [46] Expression of matrix metalloproteinases (MMP-2 and MMP-9) in vocal fold polyps
    Lesauskaite, Vaiva
    Uloza, Virgilijus
    Liutkevicius, Vykintas
    Pangonyte, Dalia
    MEDICINA-LITHUANIA, 2008, 44 (04): : 322 - 327
  • [47] Matrix metalloproteinases: Do MMP-2 and MMP-9 play a role in acute myeloid leukemia?
    Klein, G
    Haanemaaijer, R
    Vellenga, E
    Kamps, WA
    De Bont, ESJM
    LEUKEMIA, 2003, 17 (03) : 684 - 684
  • [48] The Effects of Chronic Immunosuppressive Treatment on Morphological Changes in Cardiac Tissue and the Balance between Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitors in the Rat Heart
    Surowka, Anna
    Zolnierczuk, Michal
    Prowans, Piotr
    Grabowska, Marta
    Kupnicka, Patrycja
    Markowska, Marta
    Olejnik-Wojciechowska, Joanna
    Szlosser, Zbigniew
    Wilk, Aleksandra
    Szumilas, Kamila
    Kedzierska-Kapuza, Karolina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [49] The Effects of Modulation of MMP-2 and MMP-9 in Angiogenesis and Invasive Potential in Retinoblastoma
    Webb, Anderson Hudgens
    Saleh, Nabil
    Gao, Bradley T.
    Lee, Ryan P.
    Lendermon, Justin B.
    Wilson, Matthew W.
    Morales, Vanessa Marie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [50] Role of boron and manganese on tissue remodeling: Induction of MMP-2 and MMP-9 keratinocyte secretion
    Chebassier, N
    Ouijja, EJ
    Viegas, I
    Knol, AC
    Dreno, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (06) : 1093 - 1093